StockWatch
·
Other Pharmaceuticals
Quarterly ResultNov 4, 2026, 05:36 PM

McKesson Q2 FY27 Net Income $1.30B; EPS $10.44

AI Summary

McKesson Corporation announced its second-quarter fiscal year 2027 financial results, reporting a net income of $1.30 billion, or $10.44 per diluted share, an increase from $1.16 billion, or $8.92 per diluted share, in the same period last year. Revenues for the quarter rose to $110.96 billion from $103.15 billion year-over-year. The company also noted an increase in total assets to $92.32 billion. Restructuring charges were $85 million for the quarter.

Key Highlights

  • McKesson Corporation reported Q2 FY27 net income of $1.30B, up from $1.16B in Q2 FY26.
  • Diluted EPS for Q2 FY27 was $10.44, compared to $8.92 in Q2 FY26.
  • Six-month FY27 net income reached $2.33B, an increase from $1.99B in the prior year period.
  • Six-month FY27 diluted EPS was $15.53, up from $15.16 in the prior year period.
  • Revenues for Q2 FY27 were $110.96B, up from $103.15B in Q2 FY26.
  • Total assets increased to $92.32B as of September 30, 2026, from $82.32B as of March 31, 2026.
  • Restructuring charges for Q2 FY27 were $85M, compared to $63M in Q2 FY26.